Oncotelic Therapeutics, Inc. Long-term Purchase Commitment, Amount
Oncotelic Therapeutics, Inc. (OTLC) reported Long-term Purchase Commitment, Amount of $4.03 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-07.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermPurchaseCommitmentAmount · last filed 2015-05-07
- Oncotelic Therapeutics, Inc. long-term purchase commitment, amount for the quarter ending 2015-03-31 was $4.03M, a 243.31% increase year-over-year.
- Oncotelic Therapeutics, Inc. long-term purchase commitment, amount for the quarter ending 2014-12-31 was $2.31M.
- Oncotelic Therapeutics, Inc. long-term purchase commitment, amount for the quarter ending 2014-09-30 was -$444.00K.
- Oncotelic Therapeutics, Inc. long-term purchase commitment, amount for the quarter ending 2014-06-30 was $1.67M.
- Oncotelic Therapeutics, Inc. long-term purchase commitment, amount for fiscal 2014 was $4.71M, a 250.26% increase from fiscal 2013.
- Oncotelic Therapeutics, Inc. long-term purchase commitment, amount for fiscal 2013 was $1.34M.
| Period end | Long-term Purchase Commitment, Amount 3 month | Long-term Purchase Commitment, Amount 6 month | Long-term Purchase Commitment, Amount 9 month | Long-term Purchase Commitment, Amount 12 month |
|---|---|---|---|---|
| 2015-03-31 | $4.03M 10-Q · filed 2015-05-07 | $6.34M derived: sum of 2 quarters · filed 2015-05-07 | $5.90M derived: sum of 3 quarters · filed 2015-05-07 | $7.57M derived: sum of 4 quarters · filed 2015-05-07 |
| 2014-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $1.87M derived: sum of 2 quarters · filed 2015-03-30 | $3.54M derived: sum of 3 quarters · filed 2015-03-30 | $4.71M 10-K · filed 2015-03-30 |
| 2014-09-30 | -$444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.22M derived: sum of 2 quarters · filed 2014-11-13 | $2.40M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $2.84M 10-Q · filed 2014-08-08 | ||
| 2014-03-31 | $1.17M 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | $1.34M 10-K · filed 2014-03-20 |